Effects of Linagliptin on active GLP-1 concentrations in subjects with renal impairment
Phase of Trial: Phase IV
Latest Information Update: 08 Mar 2017
At a glance
- Drugs Linagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 31 Aug 2018 Biomarkers information updated
- 02 May 2016 Status changed from active, no longer recruiting to completed.
- 23 Feb 2016 Planned End Date changed from 1 Jan 2016 to 1 Jun 2016, according to ClinicalTrials.gov record.